Home » Topics » Conferences

Conferences
RSS

Antiangiogenic agent TNP-470 suppresses tumorigenesis in animal model

Oct. 27, 1997

Mechanism of action elucidated for anthracycline developed by Sumitomo

Oct. 27, 1997

TOP-53: preclinical antitumor activity and pharmacokinetics

Oct. 27, 1997

MS-209 reverses MDR mediated by MRP and P-glycoprotein

Oct. 24, 1997

Synthetic retinoid with antiangiogenic/apoptosis-inducing effects from Taiho

Oct. 24, 1997

Taiho reports preclinical studies on TAS-103

Oct. 24, 1997

Preclinical studies on TZT-1027, an antitumor dolastatin 10 derivative

Oct. 24, 1997

NCA-0465: new antitumor indoloquinoxaline derivative

Oct. 24, 1997

Cellular target of new antitumor agent from Nippon Shinyaku identified

Oct. 24, 1997

Nikken presents new modulator of multidrug resistance

Oct. 24, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...